Autopsy report · NCT02238431

Down-regulated Hormonally Controlled Cycles for Vitrification-warmed Blastocyst Transfers

“no patient uptake”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Antalya IVF

Sponsor type

University, hospital or other

Conditions

Pregnancy

Interventions

Lucrin depot; OCP; Natural

Participants

0

Sites

1

Countries

Turkey (Türkiye)

Trials that died the same way

• Inhaled Recombinant Non-immunogenic Staphylokinase vs Placebo in Patients With COVID-19 - FORRIF Trial
  “No patients” (69% match in meaning)
• Specific Enteral Nutrition in Malnourished, Dialysis Patients With Chronic Kidney Disease. Efficacy, Safety, Quality of Life
  “No Patient recruitment” (68% match in meaning)
• Hepatitis C in Prison: Study of Screening and Rapid Treatment (HEPAPRIS)
  “No patient eligible” (66% match in meaning)
• Treatment for Growth Failure in Patients With X-Linked Severe Combined Immunodeficiency: Phase 2 Study of Insulin-Like Growth Factor-1
  “Insufficient patient participation” (65% match in meaning)
• Study of Resting and Exercising Body Functioning in Freeman-Sheldon Syndrome and Related Conditions
  “Lack of patient interest” (64% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.